Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease

MS Leo, RK Sivamani - Archives of Dermatological Research, 2014 - Springer
The mechanistic target of rapamycin (mTOR) is involved in the regulation of cellular growth,
proliferation, lipid synthesis, and protein translation. The mTOR pathway involves two …

[HTML][HTML] Elucidation of the mTOR pathway and therapeutic applications in dermatology

R Salido-Vallejo, G Garnacho-Saucedo… - Actas Dermo …, 2016 - Elsevier
The member of the phosphatidylinositol 3-kinase family, mammalian target of rapamycin, is
involved in modulating inflammatory response and regulating cellular processes associated …

Predominant role of mTOR signaling in skin diseases with therapeutic potential

F Karagianni, A Pavlidis, LS Malakou, C Piperi… - International Journal of …, 2022 - mdpi.com
The serine/threonine kinase mechanistic target of rapamycin (mTOR) plays a pivotal role in
the regulation of cell proliferation, survival, and motility in response to availability of energy …

The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy using …

T Roy, ST Boateng, MB Uddin, S Banang-Mbeumi… - Cells, 2023 - mdpi.com
The dysregulated phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin
(mTOR) signaling pathway has been implicated in various immune-mediated inflammatory …

[引用][C] Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin

G Monfrecola, S Lembo, G Caiazzo… - Experimental …, 2016 - Wiley Online Library
Background In the last years, a clear link between the endocrine signalling also influenced
by Western diet and the pathogenesis of acne has emerged 1, 2. In this context, a crucial …

Suppression of mTOR complex 2‐dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002

J Werzowa, D Cejka, T Fuereder… - British journal of …, 2009 - academic.oup.com
Background Inhibition of mTOR complex 1 (mTORC1) with rapamycin leads to
phosphorylation of AKT in some cancer cells, with unknown biological consequences. The …

Mammalian target of rapamycin in inflammatory skin conditions

A Balato, R Di Caprio, S Lembo… - European Journal …, 2014 - journals.sagepub.com
The conserved serine/threonine kinase mammalian target of rapamycin (mTOR) is a major
regulator of survival growth, proliferation and motility, in response to mitogens, energy and …

Role and therapeutic targeting of the PI3K/Akt/mTOR signaling pathway in skin cancer: a review of current status and future trends on natural and synthetic agents …

JC Chamcheu, T Roy, MB Uddin, S Banang-Mbeumi… - Cells, 2019 - mdpi.com
The mammalian or mechanistic target of rapamycin (mTOR) and associated phosphatidyl-
inositiol 3-kinase (PI3K)/protein kinase B (Akt) pathways regulate cell growth, differentiation …

Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation

C Buerger, N Shirsath, V Lang, A Berard, S Diehl… - PLoS …, 2017 - journals.plos.org
Psoriasis is a frequent and often severe inflammatory skin disease, characterized by altered
epidermal homeostasis. Since we found previously that Akt/mTOR signaling is …

Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild‐type and BK5.AktWT mice

O Rho, K Kiguchi, G Jiang… - Molecular …, 2014 - Wiley Online Library
In this study, we examined the impact of rapamycin on mTORC1 signaling during 12‐O‐
tetradecanoylphorbol‐13‐acetate (TPA)‐induced keratinocyte proliferation and skin tumor …